| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 670380 | 61586 | SERDOLECT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SERDOLECT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61586/61586_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61586/61586_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1250 | LUNDBECK ESPANA S.A. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 670398 | 61585 | SERDOLECT 16 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SERDOLECT 16 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 16 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61585/61585_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61585/61585_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1250 | LUNDBECK ESPANA S.A. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 670406 | 61584 | SERDOLECT 12 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SERDOLECT 12 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 12 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61584/61584_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61584/61584_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1250 | LUNDBECK ESPANA S.A. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 670422 | 61582 | SERDOLECT 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SERDOLECT 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 4 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61582/61582_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61582/61582_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1250 | LUNDBECK ESPANA S.A. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665782 | 10612002 | REVOLADE 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | REVOLADE 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10612002/10612002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10612002/10612002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2010-04-09 | 1 | 1 | 1 | 2010-04-09 | 2010-04-09 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665783 | 10612005 | REVOLADE 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | REVOLADE 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 50 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10612005/10612005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10612005/10612005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2010-04-09 | 1 | 1 | 1 | 2010-04-09 | 2010-04-09 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665944 | 07422006 | TASIGNA 150 MG CAPSULAS DURAS | TASIGNA 150 MG CAPSULAS DURAS, 112 cápsulas | 150 mg | 5 | 112 | 43 | 112 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07422006/07422006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07422006/07422006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2011-01-24 | 1 | 1 | 1 | 2011-01-24 | 2011-01-24 | 1 | 2011-07-07 | View Edit Delete | ||||||||||||
| 669622 | 61628 | FEMARA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | FEMARA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 2,5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61628/61628_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61628/61628_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 665876 | 01171013 | RAPAMUNE 0,5 mg COMPRIMIDOS RECUBIERTOS | RAPAMUNE 0,5 mg COMPRIMIDOS RECUBIERTOS, 30 comprimidos | 0,5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01171013/01171013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01171013/01171013_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2010-09-16 | 1 | 1 | 1 | 2010-09-16 | 2010-09-16 | 1 | 2011-05-24 | View Edit Delete | ||||||||||||
| 665937 | 09586002 | OSLIF BREEZHALER 150 microgramos POLVO PARA INHALACION (CAPSULA DURA) | OSLIF BREEZHALER 150 microgramos POLVO PARA INHALACION (CAPSULA DURA), 1 inhalador + 30 cápsulas | 150 microgramos/dosis | 5 | 30 | 8 | 1 inhalador + 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09586002/09586002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09586002/09586002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | FERRER INTERNACIONAL S.A. | 2011-02-04 | 1 | 1 | 1 | 2011-02-04 | 2011-02-04 | 1 | 2011-04-27 | View Edit Delete | ||||||||||||
| 665938 | 09586007 | OSLIF BREEZHALER 300 microgramos POLVO PARA INHALACION (CAPSULA DURA) | OSLIF BREEZHALER 300 microgramos POLVO PARA INHALACION (CAPSULA DURA), 1 inhalador + 30 cápsulas | 300 microgramos/dosis | 5 | 30 | 8 | 1 inhalador + 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09586007/09586007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09586007/09586007_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | FERRER INTERNACIONAL S.A. | 2011-02-04 | 1 | 1 | 1 | 2011-02-04 | 2011-02-04 | 0 | 2011-04-27 | View Edit Delete | ||||||||||||
| 666248 | 51533 | NUCLEO CMP FORTE CAPSULAS | NUCLEO CMP FORTE CAPSULAS, 30 cápsulas | 5 mg/3 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | FERRER INTERNACIONAL S.A. | 1982-06-01 | 1 | 1 | 1 | 1982-06-01 | 1997-09-01 | 1 | 2011-03-18 | View Edit Delete | ||||||||||||
| 669441 | 72154 | OLANZAPINA SUN 2,5 mg COMPRIMIDOS EFG | OLANZAPINA SUN 2,5 mg COMPRIMIDOS EFG , 28 comprimidos | 2,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72154/72154_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72154/72154_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2022-08-31 | View Edit Delete | ||||||||||||
| 669442 | 72155 | OLANZAPINA SUN 5 mg COMPRIMIDOS EFG | OLANZAPINA SUN 5 mg COMPRIMIDOS EFG , 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72155/72155_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72155/72155_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2022-09-13 | View Edit Delete | ||||||||||||
| 669444 | 72156 | OLANZAPINA SUN 7,5 mg COMPRIMIDOS EFG | OLANZAPINA SUN 7,5 mg COMPRIMIDOS EFG , 56 comprimidos | 7,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72156/72156_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72156/72156_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2022-09-01 | View Edit Delete | ||||||||||||
| 669446 | 72157 | OLANZAPINA SUN 10 mg COMPRIMIDOS EFG | OLANZAPINA SUN 10 mg COMPRIMIDOS EFG , 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72157/72157_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72157/72157_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2011-04-26 | View Edit Delete | ||||||||||||
| 669449 | 72159 | OLANZAPINA SUN 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA SUN 10 mg COMPRIMIDOS BUCODISPERSABLES EFG , 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72159/72159_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72159/72159_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2010-05-17 | 1 | 1 | 1 | 2010-05-17 | 2010-05-17 | 1 | 2011-04-26 | View Edit Delete | ||||||||||||
| 671687 | 72585 | IRBESARTAN SUN 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN SUN 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 150 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72585/72585_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72585/72585_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2010-10-14 | 1 | 1 | 1 | 2010-10-14 | 2010-10-14 | 1 | 2024-03-26 | View Edit Delete | ||||||||||||
| 671697 | 72586 | IRBESARTAN SUN 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN SUN 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 300 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72586/72586_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72586/72586_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2010-10-14 | 1 | 1 | 1 | 2024-07-23 | 2024-07-23 | 1 | 2024-09-25 | View Edit Delete | ||||||||||||
| 665791 | 08490007 | PRAMIPEXOL TEVA 0,18 mg COMPRIMIDOS EFG | PRAMIPEXOL TEVA 0,18 mg COMPRIMIDOS EFG, 100 comprimidos | 0,18 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08490007/08490007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08490007/08490007_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2011-02-21 | 1 | 1 | 1 | 2011-02-21 | 2011-02-21 | 1 | 2012-04-03 | View Edit Delete |
Page 229 of 1035, showing 20 records out of 20697 total, starting on record 4561, ending on 4580